Company Filing History:
Years Active: 2002
Title: Håkan Nyqvist: Innovator in Pharmaceutical Crystallization
Introduction
Håkan Nyqvist is a notable inventor based in Tullinge, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of crystallization processes. With a total of 2 patents to his name, Nyqvist's work focuses on improving the formulation and delivery of pharmacologically active substances.
Latest Patents
Nyqvist's latest patents include innovative processes for crystallization. The first patent, titled "Composition of Matter," provides a method for crystallizing amorphous and/or meta-stable crystalline regions of preformed particles. This process involves treating the particles with a supercritical or subcritical fluid that contains both an anti-solvent and a solvent. The resulting formulations can be used in treating allergic and inflammatory conditions of the nose or lungs.
The second patent, "Crystallization Using Supercritical or Subcritical Fluids," outlines a process for preparing crystalline particles containing a substance in solvated form. This method involves dissolving the substance in a first solvent and introducing it into an apparatus with a supercritical or subcritical fluid, which is saturated with water. Similar to his first patent, this invention also focuses on formulations that can aid in treating respiratory conditions.
Career Highlights
Håkan Nyqvist is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in drug formulation and delivery systems.
Collaborations
Throughout his career, Nyqvist has collaborated with talented professionals, including Mikael Bisrat and Saeed Moshashaee. These collaborations have further enriched his research and development efforts in the pharmaceutical field.
Conclusion
Håkan Nyqvist stands out as an influential inventor in the realm of pharmaceutical crystallization. His innovative patents and contributions to AstraZeneca highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in drug formulation and treatment methodologies.